Home
Conditions
Central Nervous System Lymphoma

Clinical trial condition

Central Nervous System Lymphoma

Explore clinical trials studying Central Nervous System Lymphoma. Study availability and eligibility vary by location and protocol.

34 public trials 12 recruiting studies

Refine in advanced search Browse all conditions

Central Nervous System Lymphoma trial results

Recruiting

Orelabrutinib Combined With Pemetrexed For Relapsed/Refractory Central Nervous System Lymphoma

NCT05209620

Conditions: Central Nervous System Lymphoma, Disease Attributes, Pathologic Processes, +2 more
Locations: Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZhou university Zhengzhou, Henan, China

View Trial Details

Recruiting

Lenalidomide Maintenance Treatment in Patients With Primary Central Nervous System Lymphoma

NCT05260619

Conditions: Central Nervous System Lymphoma
Locations: Seoul National University Bundang Hospital Seongnam-si, Please Select, South Korea

View Trial Details

Not Yet Recruiting

Golcadomide With Pemetrexed, Rituximab, and Dexamethasone for Relapsed and Refractory CNS Lymphomas

NCT07608731

Conditions: Central Nervous System Lymphoma, Large B-cell Lymphoma
Locations: Cleveland Clinic, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Not Yet Recruiting

Zillion: Zanubrutinib Combined With Chemotherapy for Newly Diagnosed CNS Lymphoma

NCT07405255

Conditions: Central Nervous System Lymphoma
Locations: Ruijin Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Completed

Trial for Patients With Newly Diagnosed Primary Central Nervous System (CNS) Lymphoma

NCT01011920

Conditions: Central Nervous System Lymphoma
Locations: University Hospital Aarhus, Denmark

Rigshospitalet, Copenhagen, Denmark

Herlev Hospital Herlev, Denmark

University Hospital Aachen, Germany

View all 54 locations

View Trial Details

Completed

Pharmacogenomics Effects on High-Dose Methotrexate Clearance in Patients With Diffuse Large B-Cell Lymphoma

NCT06031194

Conditions: Central Nervous System Lymphoma, Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, +10 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Completed

Using a Novel Functional MRI Technique to Evaluate for Neurotoxicity

NCT03342586

Conditions: Central Nervous System Lymphoma
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Nordic Study in Newly Diagnosed Primary Central Nervous System (CNS) Lymphoma

NCT01458730

Conditions: Central Nervous System Lymphoma
Locations: Elisa Jacobsen Pulczynski Aarhus, Denmark

View Trial Details

Completed

Ferumoxytol in Improving MR Imaging in Patients With High-Grade Brain Tumors or Cerebral Metastases

NCT00103038

Conditions: Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +15 more
Locations: OHSU Knight Cancer Institute Portland, Oregon, United States

View Trial Details

Completed

Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma

NCT02652715

Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma, Adult T-Cell Leukemia/Lymphoma, Anaplastic Large Cell Lymphoma, +76 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Central Nervous System Lymphoma

Central Nervous System Lymphoma trial results

Related conditions